Compare AKAM & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AKAM | MEDP |
|---|---|---|
| Founded | 1998 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.4B | 13.4B |
| IPO Year | 1999 | 2016 |
| Metric | AKAM | MEDP |
|---|---|---|
| Price | $87.58 | $562.70 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 12 |
| Target Price | $93.57 | ★ $468.82 |
| AVG Volume (30 Days) | ★ 2.2M | 243.4K |
| Earning Date | 02-19-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 0.97 | ★ 25.36 |
| EPS | 3.41 | ★ 14.32 |
| Revenue | ★ $4,133,202,000.00 | $2,358,373,000.00 |
| Revenue This Year | $7.09 | $21.43 |
| Revenue Next Year | $5.31 | $11.99 |
| P/E Ratio | ★ $25.77 | $39.72 |
| Revenue Growth | 4.21 | ★ 13.88 |
| 52 Week Low | $67.51 | $250.05 |
| 52 Week High | $103.75 | $626.26 |
| Indicator | AKAM | MEDP |
|---|---|---|
| Relative Strength Index (RSI) | 52.58 | 46.01 |
| Support Level | $87.83 | $561.83 |
| Resistance Level | $88.97 | $577.40 |
| Average True Range (ATR) | 1.68 | 10.97 |
| MACD | -0.24 | 0.79 |
| Stochastic Oscillator | 43.23 | 55.67 |
Akamai operates a content delivery network, which entails locating servers at the edges of networks so its customers, which store content on Akamai servers, can reach their own customers faster, more securely, and with better quality. Akamai has over 325,000 servers distributed over 4,100 points of presence in more than 1,000 cities worldwide. The firm also offers security and cloud computing for its customers, and those businesses have grown to be bigger than the legacy CDN.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.